RGEN (Repligen) Institutional Ownership: 113.09% (As of Jul. 12, 2026)


RGEN Repligen Corp RGEN
84 GF Score
Price $144.24
GF Value $176.82
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Repligen Institutional Ownership?

Repligen RGEN +0.20% 84 Institutional Ownership is 113.09% as of Jul. 12, 2026. GuruFocus rates RGEN with a GF Score™ of 84/100 and a GF Value™ of $176.82 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Repligen's institutional ownership is 113.09%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Repligen's Insider Ownership is 4.56%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Repligen's Float Percentage Of Total Shares Outstanding is 99.70%.

Repligen Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Repligen's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Repligen Institutional Ownership Chart

Repligen Historical Data

The historical data trend for Repligen can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 73.86 80.29 82.81 87.12 87.16 87.31 90.10 88.75 86.81 86.38
RGEN
84GF Score
Repligen Corp RGEN
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Repligen Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 113.09% mean?
Repligen (RGEN) has a Institutional Ownership of 113.09% as of Jul. 12, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Repligen and its competitors.
Is Repligen's Institutional Ownership too high?
Repligen's current Institutional Ownership is 113.09%. Overall, Repligen has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Repligen's Institutional Ownership compare to ATR and AVTR?
Repligen's Institutional Ownership of 113.09% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Repligen and its competitors. Repligen's current Institutional Ownership is 113.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Repligen stock overvalued right now?
Based on GuruFocus' analysis, Repligen (RGEN) is currently considered Modestly Undervalued. The stock's GF Value™ is $176.82, compared to a current price of $144.24 — trading 18.4% below its estimated fair value. The current Institutional Ownership is 113.09%. Repligen's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Repligen (RGEN), the current Institutional Ownership is 113.09% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Repligen (RGEN) Overvalued in 2026?

Based on GuruFocus' analysis, Repligen stock appears to be undervalued. The current stock price of $144.24 is trading 18.4% below its estimated GF Value™ of $176.82. GuruFocus considers Repligen to be Modestly Undervalued.

Key valuation signals for RGEN:

  • Institutional Ownership: 113.09%
  • GF Value™: $176.82 vs. price of $144.24 (18.4% below fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the RGEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Repligen Business Description

Other Exchanges RGN:Germany
Address 41 Seyon Street, Building 1, Suite 100, Waltham, MA, USA, 02453
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
84GF Score

Get the complete analysis for RGEN

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$144.24
Price
$176.82
GF Value